Organigram Stock Price, News & Analysis (CVE:OGI)

C$3.93 -0.02 (-0.51 %)
(As of 12/15/2017 10:59 AM ET)
Previous CloseC$3.95
Today's RangeC$3.90 - C$4.07
52-Week RangeC$1.81 - C$4.24
Volume1.31 million shs
Average Volume839,250 shs
Market CapitalizationC$430.04 million
P/E RatioN/A
Dividend YieldN/A
Beta8.33

About Organigram (CVE:OGI)

Organigram logoOrganiGram Holdings Inc., through its subsidiary, Organigram Inc., produces and sells medical marijuana in Canada. The company was founded in 2013 and is based in Moncton, Canada.

Receive OGI News and Ratings via Email

Sign-up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryCannabis
SectorHealthcare
SymbolCVE:OGI
CUSIPN/A
PhoneN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares102,556,000

Organigram (CVE:OGI) Frequently Asked Questions

What is Organigram's stock symbol?

Organigram trades on the Canadian Venture Exchange (CVE) under the ticker symbol "OGI."

When will Organigram make its next earnings announcement?

Organigram is scheduled to release their next quarterly earnings announcement on Tuesday, January, 23rd 2018. View Earnings Estimates for Organigram.

Where is Organigram's stock going? Where will Organigram's stock price be in 2017?

0 equities research analysts have issued 1 year price targets for Organigram's shares. Their predictions range from C$3.60 to C$3.60. On average, they expect Organigram's share price to reach C$3.60 in the next year. View Analyst Ratings for Organigram.

Who are some of Organigram's key competitors?

How do I buy Organigram stock?

Shares of Organigram and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Organigram's stock price today?

One share of Organigram stock can currently be purchased for approximately C$3.93.

How big of a company is Organigram?

Organigram has a market capitalization of C$430.04 million.


MarketBeat Community Rating for Organigram (OGI)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  51 (Vote Outperform)
Underperform Votes:  44 (Vote Underperform)
Total Votes:  95
MarketBeat's community ratings are surveys of what our community members think about Organigram and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Organigram (CVE:OGI) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.502.502.672.67
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: C$3.98C$3.98C$4.35C$2.63
Price Target Upside: 29.48% upside29.48% upside27.57% upside23.02% downside

Organigram (CVE:OGI) Consensus Price Target History

Price Target History for Organigram (CVE:OGI)

Organigram (CVE:OGI) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
10/12/2017Canaccord GenuityBoost Price TargetC$3.10 -> C$3.60View Rating Details
12/8/2016GMP SecuritiesUpgradeHold -> BuyView Rating Details
12/8/2016MackieBoost Price TargetC$2.00 -> C$4.35View Rating Details
4/1/2016Dundee SecuritiesUpgradeNeutral -> BuyView Rating Details
(Data available from 12/15/2015 forward)

Earnings

Earnings History for Organigram (CVE:OGI)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Organigram (CVE:OGI) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Organigram (CVE:OGI)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Organigram (CVE OGI) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Organigram (CVE:OGI)

Organigram (CVE OGI) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/7/2017Michael David TrippInsiderBuy30,000C$2.23C$66,900.00
2/3/2017Michael David TrippInsiderSell20C$2.75C$55.00
2/2/2017Michael David TrippInsiderBuy18,770C$2.77C$51,992.90
1/24/2017Denis Joseph Robert ArsenaultInsiderBuy50,000C$2.71C$135,500.00
4/7/2016Denis Joseph Robert ArsenaultDirectorBuy46,000C$0.80C$36,800.00
2/4/2016Michel BourqueDirectorBuy30,000C$0.76C$22,800.00
10/22/2015Denis Joseph Robert ArsenaultDirectorBuy3,500C$0.48C$1,680.00
10/7/2015Roger Arnold RogersDirectorBuy125,000C$0.23C$28,125.00
5/6/2015Roger Arnold RogersDirectorBuy45,000C$0.53C$23,625.00
5/5/2015Denis Joseph Robert ArsenaultDirectorBuy20,000C$0.50C$10,000.00
(Data available from 1/1/2013 forward)

Headlines

Organigram (CVE OGI) News Headlines

Source:
DateHeadline
Nutraceutical Influence in Cannabinoid - CBD-Based Products Boosting Revenues as Global Opportunities Emerge - PR Newswire (press release)Nutraceutical Influence in Cannabinoid - CBD-Based Products Boosting Revenues as Global Opportunities Emerge - PR Newswire (press release)
www.prnewswire.com - November 30 at 10:54 AM
Organigram appoints VP, International Business Development, prepares for international growth - GlobeNewswire (press release)Organigram appoints VP, International Business Development, prepares for international growth - GlobeNewswire (press release)
globenewswire.com - October 24 at 8:03 AM
Organigram Confident No Risk to TSXV Listing - GlobeNewswire (press release)Organigram Confident No Risk to TSXV Listing - GlobeNewswire (press release)
globenewswire.com - October 19 at 7:06 AM
Organigram Passes First Step in Organic Re-Certification - GlobeNewswire (press release)Organigram Passes First Step in Organic Re-Certification - GlobeNewswire (press release)
globenewswire.com - October 13 at 7:42 AM
Organigram Holdings Inc (OGI) Price Target Increased to C$3.60 by Analysts at Canaccord GenuityOrganigram Holdings Inc (OGI) Price Target Increased to C$3.60 by Analysts at Canaccord Genuity
www.americanbankingnews.com - October 12 at 8:52 PM
Organigram Positioned for Substantial Growth from Edible Marijuana ProductsOrganigram Positioned for Substantial Growth from Edible Marijuana Products
globenewswire.com - October 11 at 6:10 AM
Organigram Expanding Operations, Hiring Up To 140 New Employees, Will Raise Annual Output to 25000 kg - GlobeNewswire (press release)Organigram Expanding Operations, Hiring Up To 140 New Employees, Will Raise Annual Output to 25000 kg - GlobeNewswire (press release)
globenewswire.com - October 11 at 6:10 AM
Organigram to Host New Brunswicks First-Ever Cannabis Career Fair - GlobeNewswire (press release)Organigram to Host New Brunswick's First-Ever Cannabis Career Fair - GlobeNewswire (press release)
globenewswire.com - October 7 at 6:54 AM
Organigram Launches Companys First Pure CBD Cannabis Oil - BenzingaOrganigram Launches Company's First Pure CBD Cannabis Oil - Benzinga
www.benzinga.com - September 1 at 6:43 AM
Organigram to Present at Canaccord Genuity Annual Growth Conference - BenzingaOrganigram to Present at Canaccord Genuity Annual Growth Conference - Benzinga
www.benzinga.com - August 10 at 6:28 AM
Organigram Holdings Inc (CVE:OGI) to Release Quarterly Earnings on MondayOrganigram Holdings Inc (CVE:OGI) to Release Quarterly Earnings on Monday
www.americanbankingnews.com - July 22 at 11:27 AM
Opportunity of the Decade for Canadas Cannabis Companies - PR Newswire (press release)Opportunity of the Decade for Canada's Cannabis Companies - PR Newswire (press release)
www.prnewswire.com - July 20 at 5:23 AM
Canada on track to legalize recreational pot by July 2018 - NasdaqCanada on track to legalize recreational pot by July 2018 - Nasdaq
www.nasdaq.com - April 14 at 8:03 AM
IIROC Trading Halt - ACB EMC OGIIIROC Trading Halt - ACB EMC OGI
www.marketwatch.com - April 11 at 10:44 AM
OrganiGram Holdings Inc (OGI.V)OrganiGram Holdings Inc (OGI.V)
www.reuters.com - March 30 at 7:18 PM
Health Care Sector Update for 03/29/2017: THCX.V, OGI.V, WEED.TO - NasdaqHealth Care Sector Update for 03/29/2017: THCX.V, OGI.V, WEED.TO - Nasdaq
www.nasdaq.com - March 30 at 12:45 AM
Marijuana stocks jump on legalization reportsMarijuana stocks jump on legalization reports
www.theglobeandmail.com - March 27 at 6:30 PM
Cannabis: This is No Bubble, It’s Just StartingCannabis: This is No Bubble, It’s Just Starting
www.baystreet.ca - March 23 at 7:30 PM
Cannabis Companies Continue to Invest in Infrastructure and Grow Facilities to Keep up With Rising DemandCannabis Companies Continue to Invest in Infrastructure and Grow Facilities to Keep up With Rising Demand
www.bizjournals.com - March 15 at 9:37 AM
Organigram Announces Issuance of Stock OptionsOrganigram Announces Issuance of Stock Options
www.marketwatch.com - March 14 at 6:32 PM
About: Organigram Holdings, (OGRMF) - Seeking AlphaAbout: Organigram Holdings, (OGRMF) - Seeking Alpha
seekingalpha.com - March 8 at 3:36 PM

SEC Filings

Organigram (CVE:OGI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Organigram (CVE OGI) Stock Chart for Friday, December, 15, 2017

Loading chart…

This page was last updated on 12/15/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.